275 related articles for article (PubMed ID: 22323829)
1. Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses.
Garaude J; Kent A; van Rooijen N; Blander JM
Sci Transl Med; 2012 Feb; 4(120):120ra16. PubMed ID: 22323829
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
[TBL] [Abstract][Full Text] [Related]
3. Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunity.
Lin KH; Chang LS; Tian CY; Yeh YC; Chen YJ; Chuang TH; Liu SJ; Leng CH
Sci Rep; 2016 Apr; 6():24199. PubMed ID: 27063435
[TBL] [Abstract][Full Text] [Related]
4. Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model.
Nguyen CT; Hong SH; Sin JI; Vu HV; Jeong K; Cho KO; Uematsu S; Akira S; Lee SE; Rhee JH
Vaccine; 2013 Aug; 31(37):3879-87. PubMed ID: 23831323
[TBL] [Abstract][Full Text] [Related]
5. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
[TBL] [Abstract][Full Text] [Related]
6. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus.
Zhao Y; Yang J; Shi J; Gong YN; Lu Q; Xu H; Liu L; Shao F
Nature; 2011 Sep; 477(7366):596-600. PubMed ID: 21918512
[TBL] [Abstract][Full Text] [Related]
7. Improving immunotherapy: revisiting the immunologist's little secret.
Berzofsky JA
Sci Transl Med; 2012 Feb; 4(120):120fs4. PubMed ID: 22323826
[TBL] [Abstract][Full Text] [Related]
8. Tumour immunology: A close-range dual hit for tumour immunity.
Leavy O
Nat Rev Immunol; 2012 Feb; 12(4):227. PubMed ID: 22362306
[No Abstract] [Full Text] [Related]
9. Global cellular changes induced by Legionella pneumophila infection of bone marrow-derived macrophages.
Fortier A; Faucher SP; Diallo K; Gros P
Immunobiology; 2011 Dec; 216(12):1274-85. PubMed ID: 21794945
[TBL] [Abstract][Full Text] [Related]
10. Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect.
Faham A; Altin JG
J Immunol; 2010 Aug; 185(3):1744-54. PubMed ID: 20610649
[TBL] [Abstract][Full Text] [Related]
11. Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity.
Yu X; Liu W; Chen S; Cheng X; Paez PA; Sun T; Yuan F; Wei C; Landry JW; Poklepovic AS; Bear HD; Subjeck JR; Repasky E; Guo C; Wang XY
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33468554
[TBL] [Abstract][Full Text] [Related]
12. A novel pathway for inducible nitric-oxide synthase activation through inflammasomes.
Buzzo CL; Campopiano JC; Massis LM; Lage SL; Cassado AA; Leme-Souza R; Cunha LD; Russo M; Zamboni DS; Amarante-Mendes GP; Bortoluci KR
J Biol Chem; 2010 Oct; 285(42):32087-95. PubMed ID: 20702413
[TBL] [Abstract][Full Text] [Related]
13. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity.
Kofoed EM; Vance RE
Nature; 2011 Aug; 477(7366):592-5. PubMed ID: 21874021
[TBL] [Abstract][Full Text] [Related]
14. Differential requirements for NAIP5 in activation of the NLRC4 inflammasome.
Lightfield KL; Persson J; Trinidad NJ; Brubaker SW; Kofoed EM; Sauer JD; Dunipace EA; Warren SE; Miao EA; Vance RE
Infect Immun; 2011 Apr; 79(4):1606-14. PubMed ID: 21282416
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
Marshall NA; Galvin KC; Corcoran AM; Boon L; Higgs R; Mills KH
Cancer Res; 2012 Feb; 72(3):581-91. PubMed ID: 22158905
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
Song MY; Park SH; Nam HJ; Choi DH; Sung YC
J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
[TBL] [Abstract][Full Text] [Related]
17. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin.
Vijay-Kumar M; Carvalho FA; Aitken JD; Fifadara NH; Gewirtz AT
Eur J Immunol; 2010 Dec; 40(12):3528-34. PubMed ID: 21072873
[TBL] [Abstract][Full Text] [Related]
18. Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium.
Sun YH; Rolán HG; Tsolis RM
J Biol Chem; 2007 Nov; 282(47):33897-901. PubMed ID: 17911114
[TBL] [Abstract][Full Text] [Related]
19. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
[TBL] [Abstract][Full Text] [Related]
20. Restriction of Legionella pneumophila replication in macrophages requires concerted action of the transcriptional regulators Irf1 and Irf8 and nod-like receptors Naip5 and Nlrc4.
Fortier A; Doiron K; Saleh M; Grinstein S; Gros P
Infect Immun; 2009 Nov; 77(11):4794-805. PubMed ID: 19720760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
